Citadel Advisors’s Procept Biorobotics PRCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $460K | Sell |
7,986
-4,962
| -38% | -$286K | ﹤0.01% | 4149 |
|
|
2025
Q1 | $754K | Sell |
12,948
-61,230
| -83% | -$3.57M | ﹤0.01% | 3582 |
|
|
2024
Q4 | $5.97M | Buy |
74,178
+30,561
| +70% | +$2.46M | ﹤0.01% | 1664 |
|
|
2024
Q3 | $3.49M | Buy |
43,617
+16,217
| +59% | +$1.3M | ﹤0.01% | 2042 |
|
|
2024
Q2 | $1.67M | Buy |
27,400
+9,176
| +50% | +$561K | ﹤0.01% | 2605 |
|
|
2024
Q1 | $901K | Sell |
18,224
-237,483
| -93% | -$11.7M | ﹤0.01% | 3299 |
|
|
2023
Q4 | $10.7M | Sell |
255,707
-858,580
| -77% | -$36M | ﹤0.01% | 1179 |
|
|
2023
Q3 | $36.6M | Buy |
1,114,287
+638,676
| +134% | +$21M | 0.01% | 547 |
|
|
2023
Q2 | $16.8M | Sell |
475,611
-494,029
| -51% | -$17.5M | ﹤0.01% | 902 |
|
|
2023
Q1 | $27.5M | Buy |
969,640
+299,950
| +45% | +$8.52M | 0.01% | 699 |
|
|
2022
Q4 | $27.8M | Buy |
669,690
+465,055
| +227% | +$19.3M | 0.01% | 707 |
|
|
2022
Q3 | $8.48M | Sell |
204,635
-106,248
| -34% | -$4.4M | ﹤0.01% | 1406 |
|
|
2022
Q2 | $10.2M | Buy |
310,883
+127,881
| +70% | +$4.18M | ﹤0.01% | 1274 |
|
|
2022
Q1 | $6.4M | Buy |
183,002
+46,711
| +34% | +$1.63M | ﹤0.01% | 1846 |
|
|
2021
Q4 | $3.41M | Buy |
136,291
+113,439
| +496% | +$2.84M | ﹤0.01% | 2497 |
|
|
2021
Q3 | $872K | Buy |
+22,852
| New | +$872K | ﹤0.01% | 3925 |
|